Free Trial

Acelyrin (SLRN) Institutional Ownership

→ Exposed: 10 CENT Crypto to Explode April 20th? (From True Market Insiders) (Ad)
Free SLRN Stock Alerts
$4.24
0.00 (0.00%)
(As of 04/26/2024 ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media

Institutional Ownership Changes (13F Filings) for Acelyrin (NASDAQ:SLRN)

Current
Institutional Ownership
Percentage
87.31%
Number of
Institutional Buyers
(last 12 months)
48
Total
Institutional Inflows
(last 12 months)
$652.15M
Number of
Institutional Sellers
(last 12 months)
10
Total
Institutional Outflows
(last 12 months)
$18.63M
Get SLRN Insider Trade Alerts

Want to know when executives and insiders are buying or selling Acelyrin stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

SLRN Institutional Buying and Selling by Quarter

Acelyrin Major Shareholders & Ownership History

Export to Excel
Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/14/2024Point72 Europe London LLP122,971$917K0.1%N/A0.126%
2/14/2024Superstring Capital Management LP356,924$2.66M1.9%N/A0.367%
2/14/2024Lighthouse Investment Partners LLC86,651$646K0.0%N/A0.089%
2/14/2024Sectoral Asset Management Inc.325,549$2.43M1.0%N/A0.334%
2/12/2024Capstone Investment Advisors LLC27,345$204K0.0%N/A0.028%
2/12/2024Decheng Capital LLC1,370,951$10.23M2.9%N/A1.408%
2/9/2024Dynamic Technology Lab Private Ltd14,431$108K0.0%N/A0.015%
2/7/2024Jump Financial LLC49,500$369K0.0%+152.7%0.051%
2/6/2024Swiss National Bank38,300$286K0.0%-40.2%0.039%
2/1/2024New York State Common Retirement Fund13,181$98K0.0%+84.4%0.014%
1/30/2024Zurcher Kantonalbank Zurich Cantonalbank 10,716$80K0.0%+608.3%0.011%
1/30/2024Strs Ohio42,300$315K0.0%+504.3%0.043%
1/30/2024Vontobel Holding Ltd.325,549$2.43M0.0%N/A0.334%
1/24/2024Mirae Asset Global Investments Co. Ltd.17,038$127K0.0%-15.6%0.018%
1/24/2024China Universal Asset Management Co. Ltd.11,259$84K0.0%N/A0.012%
1/16/2024 Raymond James & Associates10,522$78K0.0%-43.3%0.011%
1/12/2024SG Americas Securities LLC14,741$110K0.0%N/A0.015%
12/18/2023Vanguard Group Inc.3,189,027$32.43M0.0%+3.8%3.276%
12/6/2023Citigroup Inc.73,269$745K0.0%N/A0.075%
11/29/2023Decheng Capital Management III Cayman LLC1,548,317$15.75M4.0%-0.4%1.591%
11/21/2023Walleye Capital LLC447,355$4.55M0.0%N/A0.460%
11/15/2023Kynam Capital Management LP1,200,000$12.20M2.0%N/A1.233%
11/15/2023Adage Capital Partners GP L.L.C.100,000$1.02M0.0%-73.0%0.103%
11/14/2023venBio Partners LLC3,852,470$39.18M11.1%-0.1%3.962%
11/14/2023Schonfeld Strategic Advisors LLC202,662$2.06M0.0%+267.1%0.208%
11/14/2023Fred Alger Management LLC53,206$541K0.0%-94.7%0.055%
11/14/2023Profund Advisors LLC29,232$297K0.0%N/A0.030%
11/13/2023Eagle Asset Management Inc.358,363$3.65M0.0%-31.1%0.369%
11/13/2023CHI Advisors LLC2,262,990$23.02M6.9%-15.0%2.327%
11/13/2023FMR LLC8,961,726$89.91M0.0%+20.2%9.216%
11/13/2023Rafferty Asset Management LLC173,696$1.77M0.0%N/A0.179%
11/9/2023Citigroup Inc.73,269$745K0.0%N/A0.075%
11/8/2023 Ausdal Financial Partners Inc.21,000$214K0.0%N/A0.022%
11/8/2023Swiss National Bank64,100$652K0.0%N/A0.066%
11/8/2023 Amalgamated Bank4,281$44K0.0%N/A0.004%
11/7/2023New York State Common Retirement Fund7,149$73K0.0%N/A0.007%
11/7/2023Barclays PLC106,688$1.08M0.0%N/A0.110%
11/7/2023Jump Financial LLC19,592$199K0.0%-17.3%0.020%
10/27/2023TD Asset Management Inc75,164$764K0.0%+22.0%0.077%
10/26/2023Mirae Asset Global Investments Co. Ltd.20,196$205K0.0%N/A0.021%
Exposed: 10 CENT Crypto to Explode April 20th? (Ad)

The man who bought Bitcoin and Ethereum in 2017… and has spotted 44 different coins that have returned over 100%... Is now exposing a 10-cent coin that just partnered with Amazon…

Click For My #1 FREE Crypto for 2024
10/26/2023Strs Ohio7,000$71K0.0%N/A0.007%
10/24/2023Bank of New York Mellon Corp92,701$943K0.0%+601.1%0.095%
10/24/2023 Raymond James & Associates18,556$189K0.0%N/A0.019%
8/24/2023Perceptive Advisors LLC200,000$4.18M0.1%N/A0.206%
8/22/2023CHI Advisors LLC2,663,806$55.67M16.8%N/A2.739%
8/15/2023Braidwell LP500,000$10.45M0.3%N/A0.514%
8/14/2023Samsara BioCapital LLC2,256,022$47.15M8.3%N/A2.321%
8/14/2023Marshall Wace LLP1,161,528$24.28M0.0%N/A1.195%
8/14/2023Rock Springs Capital Management LP141,876$2.97M0.1%N/A0.146%
8/14/2023Driehaus Capital Management LLC1,758,797$36.76M0.5%N/A1.809%
8/14/2023Ghisallo Capital Management LLC70,000$1.46M0.2%N/A0.072%
8/11/2023AyurMaya Capital Management Company LP9,334,735$195.10M100.0%N/A9.604%
8/11/2023General Atlantic L.P.1,500,000$31.35M0.5%N/A1.543%
8/11/2023Sectoral Asset Management Inc.201,017$4.20M0.7%N/A0.207%
8/11/2023Landscape Capital Management L.L.C.15,426$322K0.0%N/A0.016%
8/11/2023Franklin Resources Inc.879,268$18.38M0.0%N/A0.905%
8/11/2023Artal Group S.A.1,821,214$38.06M1.2%N/A1.874%
8/11/2023JPMorgan Chase & Co.3,703,338$77.40M0.0%N/A3.810%
8/11/2023ExodusPoint Capital Management LP111,077$2.32M0.0%N/A0.114%
8/9/2023TD Asset Management Inc61,610$1.29M0.0%N/A0.063%
8/3/2023Jennison Associates LLC200,000$4.18M0.0%N/A0.206%
8/2/2023Bank of Montreal Can93,315$1.85M0.0%N/A0.096%
7/28/2023Decheng Capital Management III Cayman LLC1,554,417$32.49M10.2%N/A1.599%
(Data available from 1/1/2016 forward)

SLRN Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of SLRN shares?

During the previous two years, 52 institutional investors and hedge funds held shares of Acelyrin. The most heavily invested institutionals were AyurMaya Capital Management Company LP ($195.10M), FMR LLC ($89.91M), JPMorgan Chase & Co. ($77.40M), Samsara BioCapital LLC ($47.15M), venBio Partners LLC ($39.18M), Artal Group S.A. ($38.06M), and Driehaus Capital Management LLC ($36.76M).Learn more on SLRN's institutional investors.

What percentage of Acelyrin stock is owned by institutional investors?

87.31% of Acelyrin stock is owned by institutional investors. Learn more on SLRN's institutional investor holdings.

Which institutional investors have been buying Acelyrin stock?

Of the 48 institutional investors that purchased Acelyrin stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: AyurMaya Capital Management Company LP ($9.33M), JPMorgan Chase & Co. ($3.70M), CHI Advisors LLC ($2.66M), Samsara BioCapital LLC ($2.26M), Artal Group S.A. ($1.82M), Driehaus Capital Management LLC ($1.76M), and Decheng Capital Management III Cayman LLC ($1.55M).

How much institutional buying is happening at Acelyrin?

Institutional investors have bought a total of 35,072,872 shares in the last 24 months. This purchase volume represents approximately $652.15M in transactions.

Which Acelyrin major shareholders have been selling company stock?

Of the 10 institutional investors that sold Acelyrin stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Fred Alger Management LLC ($956.84K), CHI Advisors LLC ($400.82K), Adage Capital Partners GP L.L.C. ($270K), Eagle Asset Management Inc. ($161.69K), Swiss National Bank ($25.80K), Raymond James & Associates ($8.03K), and Decheng Capital Management III Cayman LLC ($6.10K).

How much institutional selling is happening at Acelyrin?

Institutional investors have sold a total of 1,841,290 shares in the last 24 months. This volume of shares sold represents approximately $18.63M in transactions.


Related Companies:
This page (NASDAQ:SLRN) was last updated on 4/28/2024 by MarketBeat.com Staff

From Our Partners
Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share
Colonial Metals
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
This AI Trade Machine Made 1,729%* (With 89% Wins)
Prosper Trading Academy
He Is Giving Away Bitcoin
Crypto Swap Profits
Bitcoin Rockets To Record High But Buy THIS Instead
Paradigm Press
The A.I. story nobody is telling you (Read ASAP)
TradeSmith
Man Who Predicted 2008: “This Will be Worse.”
Altimetry
Why Big Pharma is Investing Billions in This Biotech
Behind the Markets